Dosimetric comparison between Intensity Modulated Radiation Therapy (IMRT) vs dual arc Volumetric Arc Therapy (VMAT) for nasopharyngeal cancer (NPC): Systematic review and meta-analysis

被引:11
|
作者
Chen, Desiree [1 ]
Bin Cai, Shao [1 ]
Soon, Yu Yang [1 ]
Cheo, Timothy [1 ]
Vellayappan, Balamurugan [1 ]
Tan, Chek Wee [1 ]
Ho, Francis [1 ]
机构
[1] Natl Univ Hlth Syst, Dept Radiat Oncol, Singapore, Singapore
关键词
DOSE CALCULATION; MONTE-CARLO; CARCINOMA; RADIOTHERAPY; TOMOTHERAPY; ALGORITHM; RAPIDARC;
D O I
10.1016/j.jmir.2022.10.195
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background and Purpose: Previous non-randomised studies com-paring dosimetric outcomes between advanced techniques such as IMRT and VMAT reported conflicting findings. We thus sought to perform a systematic review and meta-analysis to consolidate the find-ings of these studies. Materials and Methods: We searched PUBMED and EMBASE for eligible studies from their time of inception to 10 March 2022. A ran-dom effects model was used to estimate the pooled mean differences (MDs) and their 95% confidence intervals(CIs) for target volume cov-erage, organ-at-risk(OAR) doses, monitor units(MUs) and treatment delivery times. We also performed a subgroup analysis to evaluate if different treatment planning systems (TPS) (Eclipse, Monaco and Pin-nacle) used affected the pooled mean differences. Results: A total of 17 studies (383 patients) were eligible to be included. The pooled results showed that dual arc VMAT re-duced D2% of PTV (MD = 0.71Gy,95%CI= 0.14-1.27,P = 0.01), mean left cochlea dose (MD = 2.6Gy,95%CI= 0.03-5.16,P = 0.05), mean right cochlea dose (MD = 3.4Gy,95%CI= 0.7-6.1,P = 0.01), MUs (MD = 554.9,95%CI = 245.8-863.9,P = 0.0004), treatment de-livery times (MD = 6.7mins,95%CI= 4.5-8.9,P < 0.0001) and in-tegral dose (MD = 0.97Gy,95%CI= 0.28-1.67,P = 0.006). None of the other indices were significantly better for the IMRT plans. The subgroup analysis showed that the integral dose was sig-nificantly lower only for Eclipse (MD = 0.88Gy, 95%CI = 0.14-1.63, P = 0.02). The total MUs was significantly lower only for Eclipse (MD = 1035.2, 95%CI= 624.6-1445.9, P < 0.0001) and Pin-nacle (MD = 293, 95%CI= 15.6-570.5, P = 0.04). Similarly, delivery time was also significantly lower only for Eclipse (MD = 6.1mins, 95%CI= 5.7-6.5, P < 0.0001) and Pinnacle (MD = 4.9mins, 95%CI= 2.6-7.2, P < 0.0001). The subgroup analysis however showed that target coverage was superior for the IMRT plans for both Pin-nacle (MD = 0.48Gy, 95%CI= 0.31-0.66, P < 0.0001) and Monaco (MD = 0.12Gy, 95%CI = 0.07-0.17, P < 0.0001). Conclusion: Dual-arc VMAT plans improved OAR doses, MUs and treatment times as compared to IMRT plans. The different TPS used may modify dosimetric outcomes.
引用
收藏
页码:167 / 177
页数:11
相关论文
共 50 条
  • [41] Dosimetric Comparison of Coplanar Volumetric Modulated Arc Therapy and Non-coplanar Intensity Modulated Radiation Therapy for Pancreatic Cancer
    Badkul, R. K.
    Kile, L.
    Saleh, H.
    Chen, A. M.
    Lominska, C. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E635 - E636
  • [42] A Retrospective Planning Analysis Comparing Volumetric-Modulated Arc Therapy (VMAT) to Intensity-Modulated Radiation Therapy (IMRT) for Radiotherapy Treatment of Prostate Cancer
    Elith, Craig A.
    Cao, Fred
    Dempsey, Shane E.
    Findlay, Naomi
    Warren-Forward, Helen
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2013, 44 (02) : 79 - 86
  • [43] Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer
    Lin, Jia-Fu
    Yeh, Dah-Cherng
    Yeh, Hui-Ling
    Chang, Chen-Fa
    Lin, Jin-Ching
    MEDICAL DOSIMETRY, 2015, 40 (03) : 262 - 267
  • [44] Dosimetric evalutation of volumetric modulated arc therapy (VMAT) in sinonasal cancer raiotherapy
    Donini, E.
    Magi, S.
    Ricci, S.
    Pasquini, E.
    Frezza, G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 46 - 46
  • [45] Dosimetric analysis and comparison of volumetric-modulated arc therapy versus intensity-modulated radiation therapy for liver carcinoma
    Chiang, Bing-Hao
    Schnell, Erich
    Hibbitts, Kerry
    Herman, Terence
    Ahmad, Salahuddin
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 21 (01) : 138 - 140
  • [46] Comparison of Volumetric Modulated Arc Therapy (VMAT) and Intensity Modulated Radiation Therapy (IMRT) Plannings for the Treatment of Left Sided Breast and Regional Lymphatic Tissue
    Hossain, Sabbir
    Islam, Mohammad R.
    Lee, Gabriel
    Higby, Christine
    Ahmad, Salahuddin
    Algan, Ozer
    MEDICAL PHYSICS: Fourteenth Mexican Symposium on Medical Physics, 2016, 1747
  • [47] RETRACTED: Dosimetric Comparison between Volumetric Modulated Arc Therapy (VMAT) and Intensity-Modulated Radiotherapy (IMRT) for Dental Structures of Head and Neck Cancer Patients (Retracted Article)
    Ma, Yan
    Zhou, Jianfeng
    Wang, Hongyong
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [48] COMPARISON OF VOLUMETRIC MODULATED ARC THERAPY (VMAT) VS. CONVENTIONAL RADIOTHERAPY WITH INTENSITY MODULATED RADIATION THERAPY (IMRT) BOOST IN CRANIOSPINAL IRRADIATION (CSI) OF PEDIATRIC MEDULLOBLASTOMA SIOP
    Punnakal, Anirudh Urumi
    Anand, Anil Kumar
    Chaudhoory, Amal Roy
    Garg, Charu
    Patro, Kartikeshwar
    Munjal, Ram
    Bansal, Anil Kumar
    Sharma, Ritesh
    Kumar, Rajender
    Singh, Heigrujam Malhotra
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1135 - 1136
  • [49] Dosimetric Comparison of Volumetric Modulated Arc Therapy and Intensity Modulated Radiation Therapy for Whole Brain Hippocampal Sparing Radiation Therapy Treatments
    Kendall, E.
    Higby, C.
    Algan, O.
    Ahmad, S.
    Hossain, S.
    MEDICAL PHYSICS, 2016, 43 (06) : 3587 - 3587
  • [50] Dosimetric Comparison of Intensity-Modulated Radiotherapy and Volumetric Arc Therapy for Rectal Cancer
    Oskeroglu Kaplan, Sedenay
    Akboru, Halil
    Sarali, Yunus
    Altin, Suleyman
    Unsal, Mustafa
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2019, 34 (02): : 59 - 65